Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - PRE-TAX INCOME
Pre-tax Income OCX - OncoCyte Corporation
-24.9 M
LAST VALUE
41.79%
2 YEAR CAGR
-9.55%
5 YEAR CAGR
-21.67%
10 YEAR CAGR